1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. FULCRUM THERAPEUTICS INC
Fulcrum Therapeutics Inc XNAS: FULC

Fulcrum Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Momentum Trap
about

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule ...

Read More
7.83 -0.18 (-2.25%)
237.50% Gain from 52W Low
688.9K
XNAS Volume

XNAS 11 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Low Financial Strength
27.8 / 100
Valuation Score
Expensive Valuation
18.2 / 100
Momentum Score
Technically Bullish
76.0 / 100
Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM
Analyst Price Target
8
1Yr Price target upside is 4%
7 analysts

20

S

6

W

1

O

2

T

SWOT Analysis

Fulcrum Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..